Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Biomea Fusion Q3 EPS $(0.78) Down From $(0.43) YoY

Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(0.78) per share. This is a 81.4 percent decrease over losses of $(0.43) per share from the same period last year.
byBenzinga Newsdesk
November 7, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(0.78) per share. This is a 81.4 percent decrease over losses of $(0.43) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Reported Late Monday April 10, Foghorn Therapeutics To Present Preclinical Data From Its Selective CBP And EP300 Protein Degrader Programs And Preclinical Data For FHD-286, A Selective Inhibitor Of BRG1 And BRM At AACR April 14-19 2023

By Happy Mohamed
April 11, 12:33 AM
Foghorn® Therapeutics Inc. (NASDAQ:FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that

FHTX